Interactions Between Adipose Tissue and Muscle During Menopause: Mechanisms Linking to Sarcopenic Obesity in Women of Midlife
-
By
-
Weixin Zhang
-
Qianhao Wu
-
Qianyuan Chen
-
Wenxing Qin
-
Dongfang Zhang
-
Qingrong Xu
-
Peipei Han
-
Ji Sun
-
May 4, 2026
Clinical Scorecard: Interactions Between Adipose Tissue and Muscle During Menopause: Mechanisms Linking to Sarcopenic Obesity in Women of Midlife
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Inflammation, dysregulation of adipokines, lipotoxic flux, diminished muscle output, myosteatosis |
| Target Population | |
| Care Setting | |
Key Highlights
- Sarcopenic obesity is characterized by excess body fat and reduced muscle mass/function.
- Menopausal transition accelerates fat accumulation and lean mass decline.
- Standard BMI measurements may not accurately reflect body composition changes.
- Myosteatosis negatively impacts muscle strength and is linked to metabolic disorders.
- Estrogen depletion exacerbates muscle quality and metabolic balance.
- Estrogen plays a crucial role in maintaining muscle quality and metabolic health.
Guideline-Based Recommendations
Diagnosis
Management
- Implement progressive resistance training and per-meal protein distribution.
- Address inflammation and metabolic dysregulation in treatment plans.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Middle-aged women experiencing menopausal transition.
Focus on function-first approaches to mitigate lean mass loss and promote muscle health.
Clinical Best Practices
- Assess body composition beyond BMI to identify high fat content in normal-weight women.
- Address inflammation and metabolic dysregulation in treatment plans.
- Utilize ultrasound echo intensity for scalable assessment of muscle quality.
References
